Peter McNamara
Chief Scientific OfficerDr. Peter McNamara, PhD., serves as Chief Scientific Officer at Tectonic Therapeutic, Inc. since June 2022. He served as Senior Vice President and Head of Research at Tectonic Therapeutic, Inc. since May 2021 until June 2022. Dr. McNamara joins Tectonic in May 2021 from the Genomics Institute of the Novartis Research Foundation (GNF), where he was Head of Biotherapeutics and Biotechnology, responsible for GNF's platform technologies in biotherapeutics discovery and optimization, protein sciences, structural biology, functional genomics, high through-put screening, automation and engineering. Dr. McNamara joined the GNF in 2005 as Associate Director of In vivo Pharmacology. From 2009 to 2018 he was Executive Director, Head of Pharmacology and later Executive Director, Head of General Medical Biology where he was responsible for the scientific strategies and drug discovery activities. Dr. McNamara earned his PhD and BSc in Biochemistry from the National University of Ireland at Galway and was a post-doctoral Fellow at the University of Pennsylvania where he became a member of the Faculty at the Institute for Translational Medicine and Therapeutics in the School of Medicine.
Positions
- Company NameTectonic Therapeutic, Inc.Stock CodeTECXPositionChief Scientific OfficerColleagues
- ASAlise S. ReicinPresident, CEO, Secretary & Director
- FNFrancois NaderIndependent Chair of the Board
- DLDaniel LochnerChief Financial Officer
- MKMarcella Kuhlman RuddyChief Medical Officer
- WAWashington AlvesSenior Vice President of Technical Operations
- TATimothy A. SpringerIndependent Director
- PPPraveen P. TipirneniIndependent Director
- PBPhillip B. DonenbergIndependent Director
